Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older
Go back to Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older| (NASDAQ: BNTX) | Delayed: 90.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.19 | 52 Week High | $ | |||
| Open | $90.19 | 52 Week Low | $ | |||
| Day High | $90.19 | P/E | N/A | |||
| Day Low | $90.19 | EPS | $ | |||
| Volume | 1,159 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.08 | 52 Week High | $37.39 | |||
| Open | $25.08 | 52 Week Low | $28.25 | |||
| Day High | $25.08 | P/E | 15.20 | |||
| Day Low | $25.08 | EPS | $1.65 | |||
| Volume | 125,431 | |||||
